Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: Case report und review of the current literature

Breast Care

Volumn 6, Issue 6, 2011, Pages 475-478

  Gottschalk, Ingo ^a   Berg, Christoph ^a,b   Harbeck, Nadia ^a   Stressig, Rüdiger ^c   Kozlowski, Peter ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Praenatalde   (Germany)

Author keywords

Breast cancer; Fetus; Pregnancy; Renal insufficiency; Trastuzumab

Indexed keywords

CARBOPLATIN; DOCETAXEL; TRASTUZUMAB;

ADULT; AMNION FLUID; ANHYDRAMNIOS; BLADDER; BREAST CANCER; CASE REPORT; CESAREAN SECTION; FEMALE; FETUS (ANATOMY); FETUS DISEASE; FETUS LUNG MATURATION; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; MULTIPLE CYCLE TREATMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW;

EID: 84455170684     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000335202     Document Type: Review

References (75)

1. Wallack MK, Wolf JA Jr, Bedwinek J, Denes AE, Glasgow G, Kumar B, Meyer JS, Rigg LA, Wilson-Krechel S: Gestational carcinoma of the female breast. Curr Probl Cancer 1983;7:1-58.
2. Merlob P: Infant or mother with malignant disease. Beltis 2004;12:40-49.
3. Barnes DM, Newman LA: Pregnancy-associated breast cancer: A literature review. Surg Clin N Am 2007;417-430. (Pubitemid 46711115)
4. Kelly HL, Collichio FA, Dees EC: Concomitant pregnancy and breast cancer: options for systemic therapy. Breast Dis 2006;23:2005-2095.
5. Aziz S, Pervez S, Khan S, Siddiqui T, Kayani N, Israr M, Rahbar M: Case control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma. Pathol Res Pract 2003;199:15-21. (Pubitemid 36322358)
6. McGrath S, Ring A: Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Ther Adv Med Oncol 2011;3:73-83.
7. Ring AE, Smith IA, Jones A, Shannon C, Galani E, Ellis PA: Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005;23:4192-4197. (Pubitemid 46211325)
8. Reed W, Sandstad B, Holm R, Nesland JM: The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int J Surg Pathol 2003;11:65-74. (Pubitemid 36569927)
9. German Breast Group, GBG-29: Breast cancer in pregnancy: Prospective register study for the diagnosis and treatment of breast cancer in pregnancy. www.germanbreastgroup.de/pregnancy.
10. Loibl S, Amant F, Kaufmann M, Ring A, Han S, Giermek J, Bontenbal M, Heinrigs M, Jenhard M, Mehta K, von Minckwitz G: 313 patients with breast cancer during pregnancy-results from a prospective and retrospective registry (GBG-20/BIG02-03). San Antonio Breast Cancer Symposium (SABCS) 2010;abstr 259.
11. Hahn KME, Johnson PH, Gordon N: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219-1226. (Pubitemid 44452769)
12. Cardonick E, Usmani A, Ghaffar S: Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 2010;33:221-228.
13. Loibl S, von Minckwitz G, Gwyn K: Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006; 106:237-246. (Pubitemid 43100430)
14. De Carolis S, Grimolizzi F, Garofalo S, Fatigante E, Ferrazzani S, Carducci B, Caruso A: Cancer in pregnancy: results of a series of 32 patients. Anticancer Res 2006;26:2413-2418. (Pubitemid 43980210)
15. Halaska MJ, Pentheroudakis MD, Strnad P, Stankusova H, Chod J, Robova H, Petruzelka L, Rob L, Pavlidis N: Presentation, management and outcome of 32 patients with pregnancy associated breast cancer: a matched controlled study. Breast J 2009;15:461-467.
16. Loibl S: New therapeutic options for breast cancer during pregnancy. Breast Care 2008;3:171-176. (Pubitemid 351954719)
17. Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F: Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008;19:607-613. (Pubitemid 351461028)
18. Gonzales-Angulo AM, Walters RS, Carpenter RJ, Ross MI, Perkins GH, Gwyn K, Theriault RL: Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 2004;5:317-319. (Pubitemid 39562121)
19. DeSantis M, Lucchese A, De Carolis S, Ferrazzani S, Caruso A: Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer 2000;9:235-237.
20. Gainford MC, Clemons M: Breast cancer in pregnancy: are taxanes safe? Clin Oncol 2006;18:159. (Pubitemid 43169153)
21. Potluri V, Lewis D, Burton GV: Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 2006;7:167-170. (Pubitemid 44044016)
22. Nieto Y, Santisteban M, Aramendia JM, Fernandez-Hidalgo O, Garcia-Manero M, Lopez G: Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer 2006;6:533-534.
23. Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, Genazzani AR: Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 2003;23:5225-5229. (Pubitemid 38182151)
24. Koren G, Weiner L, Lishner, M, Zemelickes D, Fingegen J: Cancer and pregnancy: identification of unanswered questions on maternal and fetal risks: Obstet Gynecol Surv 1990;45:509-514. (Pubitemid 20315932)
25. Germann N, Goffinet F, Goldwasser F: Anthracyclines during pregnancy: embryo-fetal outcome in 160. patients. Ann Oncol 2004;15:146-150. (Pubitemid 38139617)
26. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5:283-291. (Pubitemid 38541580)
27. Arlin Z, Case DC Jr, Moore J, Wiernik P, Feldman E, Saletan S, Desai P, Sia L, Cartwright K: Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukaemia (ANLL). Leukemia 1990;4:177-183. (Pubitemid 20099889)
28. Büchner T, Hiddemann W, Wörmann B, et al.: Double induction strategy for acute myoloid leukaemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood 1999;93:4116-4124. (Pubitemid 29279253)
29. Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser J: Use of platinum derivates during pregnancy. Cancer 2008;11:3069-3074.
30. Mendez LE, Mueller A, Salom E, Gonzalez-Quintero VH: Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 2003;102:1200-1202. (Pubitemid 37357098)
31. Sood AK, Shahin MS, Sorosky JI: Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001;83:599-600. (Pubitemid 33139727)
32. Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E: Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79-81. (Pubitemid 46043032)
33. Lycette JL, Dul CL, Munar M, Belle D, Chui SY, Koop DR, Nichols CR: Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer 2006;7;342-344. (Pubitemid 44717769)
34. Gainfort MC, Clemons M: Breast cancer in pregnancy: are taxanes safe? Clin Oncol 2006;18:159. (Pubitemid 43169153)
35. Sekar R, Stone PR: Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol 2007;110:507-510. (Pubitemid 47417745)
36. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A: Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010;16:76-82.
37. Paladini D, Vassallo M, D'Armiento MR, Cianciaruso B, Martinelli P: Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A 2004;70:99-100. (Pubitemid 38295841)
38. Berry DL, Theirault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN: Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-861. (Pubitemid 29109315)
39. Schapira DV, Chudley AE: Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy. Cancer 1984;54:800-803. (Pubitemid 14058429)
40. Doll DC, Ringenberg QS, Yarbo JW: Antineoplastic agents and pregnancy. Semin Oncol 1989; 16:337-346. (Pubitemid 19259007)
41. Giacalone PL, Laffargue F, Benos P: Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer 1999;86:2266-2272. (Pubitemid 30010367)
42. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G: Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992;166:781-787.
43. Vaux KK, Kahole NCO, Jones KL: Cyclophosphamide, methotrexate and cytarabine embryopathy: Is apotosis the common pathway? Birth Defects Res A 2003;67:403-408.
44. Melzer HJ: Congenital anomalies due to attempted abortion with 4-amino pteroylglutamic acid. JAMA 1956;161:1253.
45. Milunsky A, Graef JW, Gaynor MF: Methotrexate-induced congenital malformations. J Pediatr 1968;72:790-795.
46. Warkary J: Aminopterin und methotrexate: folic acid deficiency. Teratology 1978;17:353-358.
47. Bawle EV, Conard JV, Weiss L: Adult and two children with fetal methotrexate syndrome. Teratology 1998;57:51-55. (Pubitemid 28176912)
48. McElhatton PR: A review of the reproductive toxicity of methotrexate in human pregnancy. Reprod Toxicol 2000;14:549.
49. Paskulin GA, Gazzola Zen PR, Camargo Pinto LL, Rosa R, Graziadio C: Combined chemotherapy and teratogenicity. Birth Defects Res A 2005;73:634-637. (Pubitemid 41428683)
50. Zemlickis D, Lishner M, Ehrlich R, Koren G: Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratogen Carcinog Mutagen 1992;13:139-143. (Pubitemid 23253372)
51. Ohara N, Teramoto K: Successful treatment of an advanced cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamid (CAP) regimen. Case report. Clin Exp Obstet Gynecol 2000;2:123-124. (Pubitemid 30636283)
52. Rai KR, Holland JF, Glidewell OJ, et al.: Treatment of acute myelocytic leukemia: a study by the Cancer and Leukemia Group. Blood 1981;58:1203-1212. (Pubitemid 12251149)
53. Löwenberg B, Downing JR, Burnett A: Acute myeloid leukaemia. N Engl J Med 1999;341:1051-1062.
54. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
55. Bonadonna G, Zucali R, Monfardini S, deLena M, Uslenghi C: Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975;36:252-259.
56. Diehl V, Franklin J, Pfreundschuh M, et al.: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003; 348:2386-2395. (Pubitemid 36682817)
57. Aviles A, Neri N: Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001;3:173-177. (Pubitemid 34092723)
58. Turchi JJ, Villasis C: Anthracycline in the treatment of malignancy in pregnancy. Cancer 1988;61:435-440.
59. Han Jung-Yeo, Nava-Ocampo AA, Kim T-J: Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol 2005;19:557-561. (Pubitemid 40313612)
60. Peres RM, Sanseverino MTV, Guimararaes JLM, Coser V, Giuliani L, Moreira RK, Ornsten T, Schüler-Faccini L: Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multi-center study. Braz J Med Biol Res 2001;34:1551-1559. (Pubitemid 34874038)
61. Mantovani G, Gramignano G, Mais V: Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur J Obstet Gynecol Reprod Biol 2007;131:238-239. (Pubitemid 46463994)
62. Simister NE: Placental transport of immunoglobulin G. Vaccine 2003;21:3365-3369. (Pubitemid 36792087)
63. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N: The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006;91:1426-1427. (Pubitemid 44569825)
64. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan ST, Dubinsky MC: Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006;4:1225-1228.
65. Watson WJ: Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnions. Obstet Gynecol 2005;105:642-651.
66. Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL: Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol 2008; 26:1567-1569.
67. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA: Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 2005;6:354-356. (Pubitemid 41715698)
68. Waterston AM, Graham J: Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 2006; 24:321-322. (Pubitemid 46622061)
69. Azim HA Jr, Peccatori FA, Liptrott SJ, Catania C, Goldhirsch A: Breast cancer and pregnancy: how safe is trastuzumab? Nat Rev Clin Oncol 2009;6:367-370.
70. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G: Favorable pregnancy outcome following trastuzumab (herceptin) use during pregnancy-Case report and updated literature review. Reprod Toxicol 2007;23:611-613. (Pubitemid 46754746)
71. Witzel ID, Müller V, Harps E, Janicke F, Dewit M: Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008;19:191-192.
72. Beale JM, Tuohy J, Mc Dowell SJ: Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am J Obstet Gynecol 2009;201:e13-e14.
73. Barthelmes L, Gateley CA: Tamoxifen and pregnancy. Breast 2004;13:446-451. (Pubitemid 39618815)
74. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of HER2/neu oncogene. Science 1987;235:177-182. (Pubitemid 17231334)
75. Sotiron C, Pusztai L: Molecular origin of cancer gene-expression signatures in breast cancer. N Engl J Med 2009;360:790.